# FDA recall D-0127-2018

> **Claris Lifesciences Inc** · Class III · drug recall initiated 2017-11-06.

## Product

Ciprofloxacin in Dextrose (5%) Injection, USP 200 mg in 100 mL  5% Dextrose, Rx Only, (2 mg/mL), 100 mL Flexible Bag, Manufactured for: Claris LifeScience Inc. North Brunswick NJ 08902 by Claris Injectables Ltd. Gujarat, India UPC 336000008242 NDC 36000-008-249

## Reason for recall

Superpotent

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0127-2018
- **Recalling firm:** Claris Lifesciences Inc
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2017-11-06
- **Report date:** 2017-12-27
- **Termination date:** 2020-04-20

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** North Brunswick, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0127-2018

## Citation

> AI Analytics. FDA recall D-0127-2018. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0127-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*